In patients with hypertension, a mismatch exists between left ventricular (LV) chamber systolic performance and effective LV myocardial contractility. Relative wall thickness (RWT), body mass index (BMI), LV wall stress and male gender are independent correlates of this discrepancy. Standard echocardiographic indices of endocardial performance such as ejection fraction (EF) and endocardial fractional shortening (eFS) overestimate systolic performance of LV circumferential fibers, which are mostly distributed in the midwall layers. 1 Measurement of midwall fractional shortening (mFS) represents a more accurate method to quantify the effective LV systolic function, and adjustment of mFS to LV wall stress provides an afterloadindependent estimate of LV myocardial contractility. 2 The determination of mFS yields lower values than those obtained at the endocardium. The pathophysiological substrate of this discrepancy includes geometrical factors and mechanisms involving interaction among differently oriented layers. 3 As a result of the alteration in LV geometry, this phenomenon is enhanced in LV pressure-overload, and this explains the evidence of normal or even hyperdynamic LV chamber function despite reduced midwall performance in many hypertensive patients. 4 The presence of a mismatch between endocardial and midwall function in these subjects is clinically important, as it allows maintenance of LV pump performance despite intrinsic myocardial impairment. 5 However, a direct evaluation of the difference between endocardial and midwall systolic function, and of its determinants, has never been performed.
To investigate factors contributing to this discrepancy, we studied 129 patients aged X16 years, affected by stage II-III essential arterial hypertension. Patients were free from other cardiac disease, including X2 þ mitral regurgitation, mitral stenosis, aortic valve disease, overt coronary artery disease, hypertrophic cardiomyopathy, atrial fibrillation or other major arrhythmias, pacemaker implantation or heart transplantation. LV dimensions were measured by echocardiography in accordance with ASE recommendations. LV mass, RWT, eFS and EF were calculated using standard formulas. Circumferential end-systolic stress (cESS) was determined using the Gaasch formula. 6 A LV cylindrical model was used to determine mFS. 7 The eFS-cESS and mFS-cESS relations obtained in 40 age-and gender-matched controls were used to calculate predicted eFS and mFS in hypertensive patients. Stress-corrected eFS (SceFS) and mFS (ScmFS) were defined as the ratios between observed and predicted values, expressed in percentage. Stroke volume and mitral inflow parameters were measured by conventional Doppler imaging. The peak velocity of systolic (S m ) and early diastolic (E m ) wave of the mitral annulus were measured by averaging the values obtained at the septal, lateral, inferior and anterior annular sites using tissue Doppler analysis.
The following indices were calculated: (1) endocardial-midwall shortening discrepancy (EMSD), calculated as the relative difference between eFS and mFS, using the formula (eFS -mFS)/mFS; (2) stress-corrected EMSD (ScEMSD), defined as the ratio between observed and predicted EMSD, the latter determined using the EMSD-cESS regression equation obtained in the control group; (3) endocardial-midwall performance discrepancy (EMPD), calculated as the relative difference between SceFS and ScmFS, using the formula (SceFS -ScmFS)/ ScmFS. Table 1 shows the main characteristics of the study population. Stepwise multiple regression was performed by considering EMSD, ScEMSD and EMPD as the dependent variables, and age, gender, body surface area, BMI, systolic and diastolic arterial pressure, heart rate, cESS, LV mass, RWT, stroke volume, S m , mitral inflow indices, E m , E/E m ratio, trivial mitral regurgitation, diabetes, and use of each class of antihypertensive medications as covariates. EMSD was positively associated to RWT (b ¼ 0.272, P ¼ 0. and BMI (b ¼ 0.230, P ¼ 0.0071). The models explained 26.2% in the variability of EMSD, 13.1% in that of ScEMSD, and 10.7% in that of EMPD. RWT was the strongest predictor in all models, accounting for 68.0, 38.7 and 50.6% of the total variability, respectively.
These results suggest that LV geometry plays a key role in allowing maintenance of adequate LV chamber systolic performance despite depressed myocardial contractility in hypertensive subjects. RWT was identified as the strongest determinant of all indices of endocardial-midwall function discrepancy, and this reflects the opposite effects of concentric geometry on LV chamber and midwall function. 8 This is in accordance with the hypothesis that the amplification in endocardial inward shifting during systole is sustained by increased ''crossfiber'' shortening at the level of subendocardium, as this phenomenon is a function of LV wall thickness. 3 BMI was also found to be a positive determinant of all indices of endocardial-midwall function discrepancy. This suggests that obesity may be associated with more evident depression in LV midwall than chamber systolic function. This hypothesis could be in accordance with previous evidences showing an independent negative association of overweight-obesity on midwall function after removal of the compensatory effect of increased preload, with no difference in eFS in comparison with normal-weight hypertensive subjects. 9 A subsequent large-sized study has confirmed that BMI is an independent negative predictor of mFS and ScmFS in hypertensive patients, despite normality of LV chamber function. 10 In addition, female gender was negatively associated to one afterload-adjusted index of endocardial-midwall function discrepancy. This might reflect a tendency towards comparable EMSD values despite reduced LV afterload in women in comparison with men.
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Owing to the discrepancy between LV endocardial and midwall performances, the possibility of underlying systolic impairment should always be considered in patients with normal chamber function. However, assessment of midwall indices is not routinely performed in clinical practice, and this may lead to inappropriate risk stratification. 12 An accurate analysis of midwall mechanics in hypertensive subjects should be recommended in the presence of (1) concentric geometry, (2) low LV afterload, (3) overweight-obesity and (4) male gender, as these factors predict high discrepancy between chamber and midwall function, and then suggest increased probability of underlying midwall impairment. Whether the assessment of endocardial-midwall function discrepancy may provide additional prognostic information in these subjects remains to be established.
Most patients in this study were under pharmacological treatment, and this may have influenced the results. The possibility of subclinical ischemic disease and the preselection bias due to adequate acoustic windows should also be taken into account. We did not explore the endocardial-midwall functon mismatch in a control group, so that the correlates of this discrepancy in a normal population remain to be determined. This study analysed subjects under resting conditions. However, it could be clinically intriguing to evaluate the correlates of the endocardial-midwall function discrepancy during exercise. The accuracy of linear regression models in describing the determinants of complex mechanical variables such as the discrepancy indices should also be considered critically. In addition, most patients had normal indices of LV chamber function. Therefore, extension of the results to subjects with frankly reduced chamber function must be performed with caution. Lastly, the use of eFS and mFS to quantify a complex 3-dimensional phenomenon such as LV ejection relies on many geometrical assumptions. More sophisticated techniques such as 3-dimensonal echocardiography and magnetic resonance imaging may be useful to analyse the determinants of discrepancy between effective LV chamber and midwall volume shortening.
